Diabetes: Screening
The question
To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the the potential merits of implementing routine screening for Type 1 Diabetes to reduce the incidence of diabetic ketoacidosis at diagnosis.
Answered by Andrew Gwynne
In the United Kingdom, national screening programmes are introduced based on the recommendations of the UK National Screening Committee (UK NSC), an independent scientific advisory committee which advises Ministers and the National Health Service in all four countries on all aspects of population and targeted screening and supports implementation.
A proposal for screening for neonatal diabetes mellitus was submitted to the UK NSC via its 2021 annual call process. An evidence-mapping exercise was conducted at that time which concluded that there was not sufficient evidence to recommend screening for this condition.
We are aware that the UK NSC received a submission via its 2024 annual call process to consider screening for autoimmune Type 1 Diabetes through blood testing. The UK NSC is currently reviewing all annual call proposals. More information on the annual call process is available at the following link:
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →